TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Average urinary flow rate (Qave)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Serum HBV RNA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stiffness relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preterm Birth (PTB)
Endpoint domain: Mortality/survival
Primary endpoint: e' value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: left atrial strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: PSP Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: VLPFC-aDMN connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean VAS score during the first 24 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time required for a successful block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient-specific function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: pain self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Accuracy of primary diagnosis on virtual patient encounters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of primary diagnosis using symptom checkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Procedural pain intensity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of lower extremity lymphedema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: Quality of life improvement (EORTC QLQ-C30)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reduction in cancer-related fatigue (BFI scores)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Homeostatic model assessment for insulin resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Covid‐19‐related medically attended visit by day 28
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative pyloric stenosis
Endpoint domain: Adverse events/effects
Primary endpoint: 2-year occurrence of further decompensation
Endpoint domain: Mortality/survival
Primary endpoint: myostatin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hazard ratio for falls
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive function as reflected by 3MS scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Screening to randomization ratio
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Adherence to national DS health-care guidelines
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Knowledge of new medication side effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction with nurses' education
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Oral analgesic requirement at 24 h after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first oral analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tunnel enlargement rates of the anteromedial bundle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sickness absence days
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Progression on the stage of change scale for nutrition and supplement risks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Achieving the action and maintenance stage of change for nutrition and supplement risks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Median progression-free survival (PFS1 and PFS2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median proportion of time spent in target saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Use of IVIG and ASA as primary therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: umbilical cleanliness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from binary restenosis at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: 90-day modified Rankin Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: perioperative estimated blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MoCA scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Log reduction of important pathogens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Improvement in immune functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction of oxidative damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of calculated biological age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: atrioventricular valve inflow peak E
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: annular Doppler tissue imaging-derived peak e' velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Thigh pain at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PROMIS PF score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of residual back pain
Endpoint domain: Adverse events/effects
Primary endpoint: organ preservation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: grade ≥3 toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: PBC treatment costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Estimated cardiovascular risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Knee balance based on intercompartmental difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction at 1 year
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: psychological challenges to exercise
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: physical challenges to exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time taken for needle guidance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of exercise failures in needle guidance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in P1NP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: MHQ summary scores at 24 months
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rate of malunion
Endpoint domain: Adverse events/effects
Primary endpoint: PET muscle damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of terminal hair
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average width of hair
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in sACE2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Combined outcome of no bleeding on probing (BoP) and PPD ≤4 mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VISIA scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: glycosylated haemoglobin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: parental non-intrusiveness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: child involvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Participation rates
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Spherical equivalent (SE) progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Axial length (AL) changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hCG-detected pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Willingness to consume the new food
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean AUC for rewarming
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MAX rewarming temperature at 15 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comorbidity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in light spread
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in diameter of halos
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Narrowing of spokes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hazard of reoperation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: time taken for intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: patient comfort score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: cytologic sample adequacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Greater condom use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: endoscopic scoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mucus evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of abdominal distension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Spontaneous pregnancy loss
Endpoint domain: Mortality/survival
Primary endpoint: Weight gain in late pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Preference for telephone follow-up
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Nucleic acid test negative conversion time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of rehabilitation with systemic ozone therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean BCVA change from baseline to month‐24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of laser treatments
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Definitive thoracic radiotherapy (RT) effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NDI symptom score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preventive behaviors of retinopathy
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Thickness of the vaginal epithelium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Restricted Mean Survival Time (RMST)
Endpoint domain: Mortality/survival
Primary endpoint: Improvement of satiety sensation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: functional activities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean total MLSI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain scores during vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction on the SRQ-20
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction on the EPDS
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Decrease in appetite sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variation in leptin values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: duration of dose of norepinephrine ≤ 0.5 μg×kg‐1×min‐1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: External Eating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prediction of heavy alcohol use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall impairment
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: psychiatric symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: sleep and circadian dysfunction
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Mental health improvement (FCV‐19S, HAMA)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sleep quality improvement (PSQI)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Tubular isometric vacuolization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Odds of testing positive for any STI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Acts of condomless vaginal or anal intercourse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge of providers regarding pre-eclampsia management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Availability of supplies to diagnose, prevent and treat pre-eclampsia
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: BMI growth pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: sputum bacterial density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sputum inflammatory markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: multi-directional reach ability in standing position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First tension (R1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Endothelial progenitor cells (EPCs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Endothelial microparticles (EMPs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: First stroke incidence
Endpoint domain: Mortality/survival
Primary endpoint: First ischemic stroke incidence
Endpoint domain: Mortality/survival
Primary endpoint: trained quadriceps MVIC score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: untrained quadriceps MVIC score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: sit-to-stand test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average tremor index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Average percent root coverage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Soft tissue volume increases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reaction to difficult client interactions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: tolerability of tazarotene lotion
Endpoint domain: Adverse events/effects
Primary endpoint: severity of hyperpigmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: SF-36 PCS score improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Probability of choosing surgery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean duration for complete ulcer healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ulcer recurrence ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in pRNFL thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ganglion cell-inner plexiform layer thickness change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in ICP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: ERA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of adequate right colon cleansing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rate of high-quality right colon cleansing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Tcore increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tskin increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brachial artery shear rate area under the curve increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: complete SRF resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: morphological changes of SRF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opioid misuse risk
Endpoint domain: Adverse events/effects
Primary endpoint: EQ‐5D VAS scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to exclusive breastfeeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first lactation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery quality score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Reduction in RH deficiency values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DAS28-CRP score change from baseline at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with good/moderate EULAR response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients in EULAR remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intention to follow the recommendation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of EIF
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of composite cardiovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean reviewer time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Data completeness rates
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CMS changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of esophageal lesions (EDEL)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidental findings on preprocedural EGD
Endpoint domain: Adverse events/effects
Primary endpoint: Mean radiological score (RS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in plasma level of sST2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in IGF-BP2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MIC values reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Primary efficacy end point
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: En bloc resection rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Resection time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Tongue coating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first CAILS response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Worsening heart failure or cardiovascular death
Endpoint domain: Mortality/survival
Primary endpoint: competency based performance scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EQ-5D-5L score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Response to Therapy
Endpoint domain: Physiological/clinical
Primary endpoint: Incidence Rate Ratio for light-stable class after 3 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence Rate Ratio for very light-slightly increasing class after 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative success rate of maxillary anterior endodontically treated teeth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of non-REM stage 2 sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep